• Mitchell Ng
    Managing Director
  • Mitchell Ng
    Managing Director
    Mitchell is a medical student at Case Western Medical School. Mitchell graduated from Princeton University with honors, Sigma Xi, majoring in molecular biology. In college, Mitchell interned at Ferghana Partners, a healthcare investment bank. He also raised $250K in seed funding for his first start-up, ThinkIvy, a college consulting company. Mitchell has research experience, publishing his Princeton senior thesis on novel NF-kB inhibitor ASCC1 and 2 independent papers on Strategies for Alpha Oil investing. Mitchell enjoys fencing sabre and was president of Princeton Fencing Club.

    mkng@thessaluscapital.com

    Princeton University | 2016
    Molecular Biology
  • Kenneth Ng
    Managing Director
  • Kenneth Ng
    Managing Director
    Kenneth is a medical student at SUNY Downstate College of Medicine. He graduated from New York University with a 3.97 GPA Phi Beta Kappa and was a biochemistry major economics minor. Kenneth conducted research at the NIH, Columbia, and NYU in topics including Anesthesiology, Dermatology, and Developmental Genetics. Kenneth personally invested in and co-founded Novabionics, a robotic prosthetic limb company. Kenneth follows politics in his free time.

    kng@thessaluscapital.com

    NYU | 2014
    Biochemistry
  • Raj Bagaria
    Managing Director
  • Raj Bagaria
    Managing Director
    Raj is a freshman at The University of Pennsylvania in the Huntsman Program in International Studies and Business, a dual-degree program between the College of Arts and Sciences and the Wharton School. Concentrating in Finance and Healthcare Care Policy and Management, Raj plans to get involved in international venture capital funds in India. Raj graduated from the Lawrenceville School in 2017, where he lead his school’s investment club, international affairs publication, and golf team.

    rbagaria@thessaluscapital.com

    University of Pennsylvania | 2021
    Wharton / Huntsman Program
  • Ariel Kantor
    Director
  • Ariel Kantor
    Director
    Ariel is a junior at Duke University majoring in biotechnology with concentrations in finance and regulatory policy. Previously, Ariel interned at 12 West Capital, a long/short equity hedge fund and IDEA Fund Partners (a local VC firm), and is currently working at Raymond James conducting biotechnology equity research. Ariel has an extensive research background in fields of DNA damage and repair viral vector platform development through research fellowships at the NIH and Gene Therapy Center. He is currently working on developing gene-editing platforms for treatment of human genetic diseases at the Duke Department of Biomedical Engineering. A former two-sport athlete and Foot Locker Scholar-Athlete of the Year awardee, Ariel enjoys staying active and working out in his free time.

    akantor@thessaluscapital.com

    Duke University | 2019
    Biotechnology
  • John Ennis
    Director
  • John Ennis
    Director
    John is a junior at Princeton University majoring in Public and International Affairs at the Woodrow Wilson School. His future research will involve education policy and the effectiveness of financial aid. Originally from Gorham, Maine, John has worked at an eCommerce startup in Tel Aviv, Israel and studied entrepreneurship at the Inter-Disciplinary Center in nearby Herzliya. This summer, he will be working in management consulting at AlphaSights in San Francisco. Outside of academics and work, John enjoys watching “The Office” and playing golf.



    Princeton University 2020
    Finance
  • Logan Brock
    Director
  • Logan Brock
    Director
    Logan is a medical student at UPenn Perelman School of Medicine, and attended the University of Colorado-Boulder where he got a 4.0 GPA and was a US Presidential Scholar (1 of 2 from Colorado). Logan is partner at Global Platinum Securities, a student-run mutual fund founded by Harvard and MIT students, and interned at DG Capital Management LLC. Logan has extensive research experience, writing an honors thesis on efficacy of IL-10/IL-10R gene therapy on a neuropathic pain model, and conducting clinical research on ACL reconstruction surgery and Persistent Pulmonary Hypertension of the Newborn. Logan is a Ironman Triathlon Finisher and has run numerous Olympic distance races.

    lbrock@thessaluscapital.com

    Perelman School of Medicine at UPenn

Dedicated to Client Service Thessalus believes its teams of domain experts and creative managers will deliver superior service and results to clients from all over the world."